Publications by authors named "Maxime Delrue"

Claim this Profile
R
Reduced-dose versus full-dose apixaban for extended treatment of cancer-associated venous thromboembolism: A systematic review and meta-analysis of randomized controlled trials with trial sequential analysis.
Benjamin Crichi, Maxime Delrue, Tamim Alsuliman, Sylvain Le Jeune, Corinne Frere

Thromb Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interference with immunofixation in a dabigatran-overdosed patient treated with idarucizumab: beware of a diagnostic pitfall.
Quentin Pomorski, Maxime Delrue, Ellias Bato, Mayssa Selmi, Bruno Megarbane

Clin Chem Lab Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary cement embolism following cement-augmented pedicle screw fixation in a patient with metastatic vertebral compression fracture: A case report and management considerations.
Mohammad Daher, Victor Percheron, Adrien Lampilas, Amer Sebaaly, Guillaume Riouallon, Maxime Delrue

J Vasc Surg Cases Innov Tech· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced-dose direct oral anticoagulants for the secondary prevention of venous thromboembolism: finding the sweet spot.
Benjamin Crichi, Maxime Delrue, Corinne Frere

Res Pract Thromb Haemost· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibrinography and thrombography (thrombodynamics-4D) in atrial fibrillation assessment of direct oral anticoagulants in geriatrics patients aged 80 years and older receiving direct oral anticoagulant therapy.
Geoffrey Foulon-Pinto, Georges Jourdi, Maxime Delrue, Carmelo Lafuente-Lafuente, Candice Cavalie

Res Pract Thromb Haemost· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebral Venous Thrombosis and Nitrous Oxide Intoxication: Report of Two Cases and Review of the Literature.
Diana Doukhi, Virginie Siguret, Dominique Vodovar, Maxime Delrue, Peggy Reiner

Brain Behav· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Influencing Anti-Xa Assays: A Multicenter Prospective Study in Critically Ill and Noncritically Ill Patients Receiving Unfractionated Heparin.
Dominique Lasne, Marie Toussaint-Hacquard, Céline Delassasseigne, Anne Bauters, Claire Flaujac, Maxime Delrue

Thromb Haemost· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among noncritically and critically ill patients with COVID-19: the COVI-DOSE trial, a multicenter, randomised, open-label, phase 4 trial.
Stéphane Zuily, Benjamin Lefèvre, Olivier Sanchez, Ombeline Empis de Vendin, Guillaume de Ciancio, Maxime Delrue

EClinicalMedicine· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of DOAC in GEriatrics (Adage Study): Rivaroxaban/Apixaban Concentrations and Thrombin Generation Profiles in NVAF Very Elderly Patients.
Geoffrey Foulon-Pinto, Carmelo Lafuente-Lafuente, Georges Jourdi, Julien Le Guen, Fatoumata Tall, Maxime Delrue

Thromb Haemost· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical Nomogram Predicting Apixaban or Rivaroxaban Concentrations from Low-Molecular-Weight Heparin Anti-Xa Values: Special Interest in Acute Ischemic Stroke Patients.
Charlyne Brakta, Alain Stépanian, Peggy Reiner, Maxime Delrue, Mikaël Mazighi

J Stroke· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No VTE Recurrence After 1-Year Follow-Up of Hospitalized Patients With COVID-19 and a VTE Event: A Prospective Study.
Maxime Delrue, Alain Stépanian, Sebastian Voicu, Kladoum Nassarmadji, Damien Sène

Chest· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case series of massive direct oral anticoagulant ingestion-Treatment and pharmacokinetics data.
Maxime Delrue, Lucie Chevillard, Alain Stépanian, Alessandra Dragoni, Laurence Camoin-Jau

Eur J Clin Invest· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
White blood count, D-dimers, and ferritin levels as predictive factors of pulmonary embolism suspected upon admission in noncritically ill COVID-19 patients: The French multicenter CLOTVID retrospective study.
Joris Galland, Benjamin Thoreau, Maxime Delrue, Marie Neuwirth, Alain Stepanian

Eur J Haematol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Lupus anticoagulant and ischemic strokes: about two case reports].
Julie Hilaire, Clara Noizat, Minh-Toan Duong, Maxime Delrue, Dominique Hervé

Ann Biol Clin (Paris)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contrast between Prevalence of HIT Antibodies and Confirmed HIT in Hospitalized COVID-19 Patients: A Prospective Study with Clinical Implications.
Maxime Delrue, Virginie Siguret, Marie Neuwirth, Caren Brumpt, Sebastian Voicu

Thromb Haemost· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unexpected acute pulmonary embolism in an old COVID-19 patient with warfarin overdose: a case report.
Maxime Coutrot, Maxime Delrue, Bérangère S Joly, Virginie Siguret

Eur Heart J Case Rep· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
D-Dimer Level and Neutrophils Count as Predictive and Prognostic Factors of Pulmonary Embolism in Severe Non-ICU COVID-19 Patients.
Benjamin Thoreau, Joris Galland, Maxime Delrue, Marie Neuwirth, Alain Stepanian

Viruses· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
von Willebrand factor/ADAMTS13 axis and venous thromboembolism in moderate-to-severe COVID-19 patients.
Maxime Delrue, Virginie Siguret, Marie Neuwirth, Bérangère Joly, Nicolas Beranger

Br J Haematol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of subcutaneous preemptive rituximab in immune-mediated thrombotic thrombocytopenic purpura: Experience from the first 12 cases.
Maxime Delrue, Minh Tam Baylatry, Anne-Christine Joly, Elise Corre, Zora Marjanovic

Am J Hematol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are antiphospholipid antibodies associated with thrombotic complications in critically ill COVID-19 patients?
Virginie Siguret, Sebastian Voicu, Marie Neuwirth, Maxime Delrue, Etienne Gayat

Thromb Res· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential usefulness of activated charcoal (DOAC remove®) for dRVVT testing in patients receiving Direct Oral AntiCoagulants.
Georges Jourdi, Maxime Delrue, Alain Stepanian, Jessica Valaize, Geoffrey Foulon-Pinto

Thromb Res· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis